Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy

Search

The Project
About DMD
Study Information
Drug Development
- Development of Vamorolone
- Vamorolone development programme
Funding Model
- Patient Group Funders
- What is Venture Philanthropy?
Resources
English
- Nederlands
- Français
- Deutsch
- Italiano
- Español

Contact us

Your name*

Your email address*

Your message*

reCAPTCHA

Email Address

If you are human, leave this field blank.

Follow us on twitter

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 667078.

To find out more about the project contact us at vision-dmd_team@ceratium.eu

Multilingual WordPress with WPML

Cookies

This site uses cookies: Find out more.